Your browser doesn't support javascript.
loading
OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues.
Wunderlich, Mark; Brooks, Ryan A; Panchal, Rushi; Rhyasen, Garrett W; Danet-Desnoyers, Gwenn; Mulloy, James C.
Afiliación
  • Wunderlich M; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and.
  • Brooks RA; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and.
  • Panchal R; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and.
  • Rhyasen GW; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and.
  • Danet-Desnoyers G; Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Mulloy JC; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH; and.
Blood ; 123(24): e134-44, 2014 Jun 12.
Article en En | MEDLINE | ID: mdl-24778156

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Muromonab-CD3 / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Inmunosupresores Tipo de estudio: Etiology_studies / Guideline Límite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Muromonab-CD3 / Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped / Inmunosupresores Tipo de estudio: Etiology_studies / Guideline Límite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Blood Año: 2014 Tipo del documento: Article